AI assistant
Imunon, Inc. — Capital/Financing Update 2020
Oct 23, 2020
35124_rns_2020-10-23_ab72b7b1-64c5-47f8-bb15-6652fc4752d0.zip
Capital/Financing Update
Open in viewerOpens in your device viewer
CORRESP 1 filename1.htm
997 Lenox Drive, Suite 100
Lawrenceville, New Jersey 08648
Telephone: (609) 896-9100
October 23, 2020
Via EDGAR and E-Mail
Division of Corporation Finance
Securities and Exchange Commission
Washington, D.C. 20549
| RE: |
|---|
| Registration |
| Statement on Form S-3 |
| Filed: |
| October 9, 2020 |
| File |
| No. 333-249420 |
Dear Ladies and Gentlemen:
In accordance with Rule 461 promulgated under the Securities Act of 1933, as amended, Celsion Corporation hereby requests acceleration of the effectiveness of its Registration Statement on Form S-3 (Reg. No. 333-249420) to 5:00 p.m., Eastern time, on Tuesday, October 27, 2020, or as soon thereafter as is practicable.
Very truly yours,
| Celsion Corporation | |
|---|---|
| By: | /s/ |
| Jeffrey W. Church | |
| Jeffrey | |
| W. Church | |
| Executive | |
| Vice President and Chief Financial Officer |
cc: Steven G. Canner, Esq.
Baker & McKenzie LLP
Field: Page; Sequence: 1; Options: Last
Field: /Page